FDA Adverse Event Injury Summary report: N

REJUVENATE STRGHT PRFIT TMZF MOD STEM SIZE 10

MDR report key: 2912046 · Received January 11, 2013

Report

Report Number
0002249697-2013-00028
Event Type
Injury
Date Received
January 11, 2013
Date of Event
December 27, 2012
Report Date
December 27, 2012
Manufacturer
STRYKER ORTHOPAEDICS-MAHWAH
Product Code
MEH
PMA / PMN Number
K092561
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AN EVALUATION OF THE DEVICE CANNOT BE PERFORMED AS THE DEVICE WAS NOT RETURNED TO THE MANUFACTURER DUE TO HOSPITAL POLICY. ADDITIONAL INFORMATION (INCLUDING X-RAYS AND MEDICAL RECORDS) HAS BEEN REQUESTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THE EVALUATION SUMMARY WILL BE SUBMITTED IN A SUPPLEMENTAL REPORT. (B)(4).

Additional Manufacturer Narrative · 1

THE PATIENT IS (B)(6) IN HEIGHT. AN EVENT REGARDING ALTR INVOLVING A REJUVENATE MODULAR DEVICE WAS REPORTED. THE EVENT WAS CONFIRMED. REVIEW OF DEVICE HISTORY RECORDS FOUND THE DEVICES IN THE REPORTED LOT WERE ACCEPTED INTO FINAL STOCK WITH NO REPORTED DISCREPANCIES. THE COMPLAINT DATABASES SHOW THERE HAVE BEEN OTHER EVENTS FOR THE REPORTED LOT. SIMILAR EVENTS HAVE OCCURRED FOR THE CATALOG NUMBER AND PRODUCT FAMILY. THESE EVENTS WERE DETERMINED TO BE ASSOCIATED WITH RA 2012-067. VOLUNTARY RECALL RA 2012-067 WAS INITIATED FOR ABGII AND REJUVENATE MODULAR STEMS AND NECKS DUE TO THE POTENTIAL RISKS ASSOCIATED WITH THESE DEVICES. THE REPORTED ALTR IS CONSIDERED TO BE UNDER THE SCOPE OF THIS RECALL.

Description of Event or Problem · 1

PATIENT HAD ADVERSE LOCAL TISSUE REACTION.

Description of Event or Problem · 1

UPDATE: IT WAS REPORTED THAT: "PATIENT HAS INJURIES SUSTAINED AS A RESULT OF THE IMPLANTATION OF A STRYKER REJUVENATE HIP REPLACEMENT."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
17563 REJUVENATE STRGHT PRFIT TMZF MOD STEM SIZE 10 IMPLANT MEH STRYKER ORTHOPAEDICS-MAHWAH MHNAK1

Patients

Seq Age Sex Outcome Treatment
1 52 YR Required Intervention